Olema Pharmaceuticals: director resigns, committee appointments

What happened

• Olema Pharmaceuticals filed an 8-K reporting that Dr. Gorjan Hrustanovic notified the company on Oct 12, 2026 that he would resign from the company’s Board of Directors, effective Oct 14, 2026. The filing says Dr. Hrustanovic also resigned from the Compensation Committee and the Science and Technology Committee and that his resignation was not the result of any disagreement with the company on any matter relating to the company’s operations, policies or practices.
• The filing reports that on Oct 15, 2026, upon the recommendation of the Nominating and Corporate Governance Committee, the Board appointed Dr. Prakash Raman to the Compensation Committee and to the Science and Technology Committee, each effective Oct 15, 2026. The report was signed by Sean Bohen on Oct 15, 2026.

Key details

• Dr. Gorjan Hrustanovic notified the company on Oct 12, 2026 and resigned effective Oct 14, 2026.
• He resigned from the Compensation Committee and the Science and Technology Committee.
• The Board appointed Dr. Prakash Raman to the Compensation Committee and the Science and Technology Committee, effective Oct 15, 2026, based on the Nominating and Corporate Governance Committee’s recommendation.
• The filing was signed by Sean Bohen, M.D., Ph.D., on Oct 15, 2026.

Why it may matter

• This report was submitted under Item 5.02, "Departure of directors or certain officers; election of directors," which covers resignations of directors and related committee changes. A filing does not show why the insider traded or why the company acted.